
    
      Double-blind, randomized, placebo controlled, multicenter, phase 4 clinical trial to assess
      the efficacy and safety of MUCOLASE tablet (streptokinase â€¢ streptodornase) in patients with
      acute upper respiratory infection or acute bronchitis
    
  